Onzuka Tatsushi, Shimizu Ichiro, Tomita Yukihiro, Iwai Toshiro, Okano Shinji, Tominaga Ryuji
Department of Cardiovascular Surgery, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.
Surg Today. 2008;38(9):807-14. doi: 10.1007/s00595-007-3715-1. Epub 2008 Aug 28.
PURPOSE: Hyperacute rejection (HAR) mediated by the natural antibody (nAb) against Gal alpha 1-3Gal beta-4-GlcNAc (alpha Gal) is the major obstacle in xenogeneic organ transplantation. Previously, we reported the acceptance of donor heart grafts in anti-alpha Gal nAb-producing galactosyltransferase knockout (GalT KO) mice after cyclophosphamide (CP)-induced tolerance conditioning. In the present study, we applied our tolerance induction conditioning in presensitized recipient mice. METHODS: GalT KO (alpha Gal(-/-), H-2(b/d)) recipient mice were presensitized with alpha Gal(+) rabbit red blood cells (RRBCs). Presensitized or nonsensitized recipient mice were treated with CP-induced tolerance conditioning, consisting of AKR (alpha Gal(+/+), H-2(k)) spleen cells (SC), CP, busulfan (BU), and AKR bone marrow cells (BMC). We assessed the survival of donor hearts and skin grafts and analyzed the production of anti-alpha Gal Abs by flow cytometry. RESULTS: Donor mixed chimerism was achieved in the presensitized GalT KO mice treated with CP-induced tolerance conditioning. In parallel with the disappearance of anti-alpha Gal Abs, permanent acceptance of donor heart grafts and skin grafts was observed in presensitized and GalT KO mice treated with CP-induced tolerance conditioning. CONCLUSIONS: Both B-cell and T-cell tolerance was achieved in the presence of a higher titer of anti-alpha Gal Abs after treatment with CP-induced tolerance conditioning.
目的:由针对Galα1-3Galβ-4-GlcNAc(αGal)的天然抗体(nAb)介导的超急性排斥反应(HAR)是异种器官移植的主要障碍。此前,我们报道了在环磷酰胺(CP)诱导的耐受性预处理后,产生抗αGal nAb的半乳糖基转移酶敲除(GalT KO)小鼠接受供体心脏移植。在本研究中,我们将耐受性诱导预处理应用于预先致敏的受体小鼠。 方法:用αGal(+)兔红细胞(RRBCs)对GalT KO(αGal(-/-),H-2(b/d))受体小鼠进行预先致敏。对预先致敏或未致敏的受体小鼠进行CP诱导的耐受性预处理,包括AKR(αGal(+/+),H-2(k))脾细胞(SC)、CP、白消安(BU)和AKR骨髓细胞(BMC)。我们评估了供体心脏和皮肤移植的存活情况,并通过流式细胞术分析了抗αGal抗体的产生。 结果:在接受CP诱导的耐受性预处理的预先致敏的GalT KO小鼠中实现了供体混合嵌合。随着抗αGal抗体的消失,在接受CP诱导的耐受性预处理的预先致敏和GalT KO小鼠中观察到对供体心脏移植和皮肤移植的永久接受。 结论:在CP诱导的耐受性预处理后,在抗αGal抗体滴度较高的情况下实现了B细胞和T细胞耐受性。
Scand J Immunol. 2005-9
Transplantation. 2000-9-27
Scand J Immunol. 2006-10
Scand J Immunol. 2005-9
Xenotransplantation. 2005-7
Xenotransplantation. 2004-1